Filter Results:
(297)
Show Results For
- All HBS Web
(693)
- People (2)
- News (222)
- Research (297)
- Events (4)
- Multimedia (12)
- Faculty Publications (183)
Show Results For
- All HBS Web
(693)
- People (2)
- News (222)
- Research (297)
- Events (4)
- Multimedia (12)
- Faculty Publications (183)
Sort by
- 25 Sep 2019
- Research & Ideas
The Economic Cost of Physician Burnout
Physician burnout costs the United States health care industry $4.6 billion a year, a number that brings a new spotlight to an age-old problem. In a paper published in the journal Annals of Internal Medicine this past June, a research... View Details
- 14 Jul 2020
- Research & Ideas
Restarting Under Uncertainty: Managerial Experiences from Around the World
further improve efficiency, the number of stock-keeping units were reduced from about 4,000 to 1,000+, and offered special packages that included vegetables, fruit, meat, and medicine to accelerate sorting and delivery. Case 3: Product... View Details
- 03 Dec 2001
- Research & Ideas
Healthcare Conference Looks At Ailing Industry
medicine is that most therapeutics were directed at symptoms, not causes.—Eric S. Lander With that in mind, about 200 HBS alumni working in the healthcare field converged in mid-November at the Charles Hotel in Cambridge to learn from... View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
developments suggest that doctors will eventually be able to treat patients more effectively with medicine tailored to their genetic makeup, including, in some cases, gene replacement therapies. "The drug market may become much more... View Details
- 28 Nov 2016
- Research & Ideas
Challenging the Belief that Liability Laws Kill Medical Device Innovation
Defensive medicine spurs innovation They found, ultimately—and perhaps counterintuitively—that far from being an inhibitor to innovation, the practice of defensive medicine might have actually encouraged it.... View Details
- 29 May 2001
- Research & Ideas
Genomics: Can We Start Making Money Now?
predict a new world where drug treatments are customized to an individual's genetic makeup, and gene-based therapy can root out cancer and other diseases before they take hold in the body. The new science will "revolutionize the way View Details
Keywords: by Sean Silverthorne
- 12 Dec 2022
- Research & Ideas
Buy-In from Black Patients Suffers When Drug Trials Don’t Include Them
October. However, when the drug testing panel includes a proportionate share of Black participants, doctors are much more willing to write a prescription. Black patients, in turn, were more likely to trust a medicine when clinical trials... View Details
- 16 Aug 2016
- First Look
August 16, 2016
administration (11.7%), biotech/device/pharmaceutical (10.9%), and entrepreneurship (9.5%). Overall, 84% of physician-MBAs entered residency; approximately half (49.3%) remained clinically active in some capacity and only one-fourth (27.7%) reported clinical View Details
Keywords: Sean Silverthorne
- 24 Sep 2007
- Research & Ideas
The FDA: What Will the Next 100 Years Bring?
world's premier regulator of food, drugs, cosmetics, and other products and also of helping to lead the transformation of medicine to a molecular level. Current logistical challenges include ever-more rapid movement of products across... View Details
- 23 Jan 2008
- First Look
First Look: January 23, 2008
Authors:Michel Anteby and Mikell Hyman Periodical:Social Science & Medicine (forthcoming) Abstract Human cadavers are crucial to medical science. While the debate on how to secure sufficient cadavers has focused primarily on donors'... View Details
Keywords: Martha Lagace
- 07 Mar 2018
- Research & Ideas
Electronic Health Records Were Supposed to Cut Medical Costs. They Haven't.
annoyed, and it distracts them from dealing with the patient.” The study, published in the February 20 issue of the Journal of the American Medical Association, looked at five types of visits: primary care visits, ER visits resulting in a patient discharge, general... View Details
- 22 May 2020
- In Practice
Post-COVID Health Care: More Screens, Less Red Tape?
Fetter, a senior lecturer, is former CEO of Tenet Healthcare. Regulations that limit care might be loosened Richard Hamermesh: Cutting the red tape in diagnostic testing The crisis has revealed the weakest part of our medical system—the lack of rewards for diagnostics.... View Details
Keywords: by Danielle Kost
- 08 Mar 2017
- Op-Ed
Op-Ed: Can the Proposed American Health Care Act Improve on 'Obamacare'?
it passes in Congress. About the Authors John A. Quelch is the Charles Edward Wilson Professor of Business Administration at Harvard Business School. He also holds a joint appointment at Harvard T.H. Chan School of Public Health as Professor in Health Policy and... View Details
- 02 Sep 2010
- What Do You Think?
How Transparent Should Boards Be?
his way. In John Caddell's words, "The CEO made mistakes. The board did as well-the hired the wrong guy Both need to take their medicine So, the answer is: pay the man now. Move on." In Guishan Longani's words, " avoid the... View Details
Keywords: by Jim Heskett
- 04 May 2007
- What Do You Think?
How Do Managers Think?
key success factor—like with doctors (is) management's willingness to hear as input in their decision processes." Alberto Souto said, "Both medicine and management are socio-technologies plus art . There is still a lot of... View Details
Keywords: by Jim Heskett
- 19 Nov 2014
- HBS Case
Marketing Marijuana
segment shows different dynamics in terms of its sensitivity to price, marketing, and convenience. Medicinal consumers, for example, do not care so much about variety. "Once you find the strain and supply source that best alleviates... View Details
- 05 Sep 2012
- What Do You Think?
Will Business Management Save US Health Care?
doctors and hospitals to remove the cartel and guild aspects of medicine and put more of the purse strings directly into the consumers' hands " Addressing incentives, Tom Dolembo suggested that "We should pay doctors well who... View Details
- 18 Jul 2018
- Research & Ideas
No More General Tso's? A Threat to 'Knowledge Recombination'
pharmaceutical companies, which had been flying in scientists from China and India who, like Cohly, brought knowledge of native herbs. Some pharma companies were able to earn exemptions from the H1-B limits. Choudhury and Kim used this discrepancy to create a database... View Details
- 13 Feb 2006
- Research & Ideas
The Hidden Market for Babies
reproductive medicine have indeed created a market for babies, a market in which parents choose traits, clinics woo clients, and specialized providers earn millions of dollars a year. In this market, moreover, commerce often runs without... View Details
- 13 Dec 2006
- Research & Ideas
Improving Public Health for the Poor
School of Public Health, Project Antares aims to create a system for devising commercial incentives that provide affordable public health initiatives, or "interventions" in healthcare parlance. Examples of commercial high-impact interventions might be... View Details